Production (Stage)
Vigil Neuroscience, Inc.
VIGL
$7.89
$0.010.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.77% | -1.96% | -4.66% | -10.42% | -13.77% |
| Total Depreciation and Amortization | 3.80% | 13.53% | 47.56% | 105.96% | 257.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.24% | 13.49% | 41.04% | 37.98% | 31.88% |
| Change in Net Operating Assets | 631.85% | 630.08% | 3,182.24% | 265.93% | 187.24% |
| Cash from Operations | 24.01% | 27.20% | 32.45% | 0.49% | -1.25% |
| Capital Expenditure | -59.34% | 99.26% | 98.07% | 95.01% | 85.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.93% | 113.60% | 115.45% | 148.12% | 129.94% |
| Cash from Investing | -23.66% | 113.45% | 115.23% | 147.37% | 129.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 95.35% | 72.73% |
| Issuance of Common Stock | 202.04% | 962.57% | 443.84% | -89.71% | -88.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 540.19% | 3,220.95% | 2,582.37% | -92.66% | -91.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.68% | 90.36% | 91.91% | 76.24% | 35.22% |